High-intensity focused ultrasound (HIFU) has shown promise as a pain management strategy in patients with bone metastases for whom other treatments are ineffective, according to researchers at the Sheba Medical Center in Israel (Ann Oncol 2007;18:163-167).
High-intensity focused ultrasound (HIFU) has shown promise as a pain management strategy in patients with bone metastases for whom other treatments are ineffective, according to researchers at the Sheba Medical Center in Israel (Ann Oncol 2007;18:163-167).
The goal of treatment for bone metastases is to relieve pain and reduce the risk of fracture. Treatment may consist of surgery, radiation therapy, pain medications, and/or bisphosphonate drugs.
In the study, 10 patients reported prolonged improvement in pain and/or a reduced dose of pain medication following MR-guided ultrasound ablation of bone metastases. One other patient found the MR-guided HIFU procedure too uncomfortable to complete treatment.
MR-guided HIFU is approved in the U.S. only for uterine fibroids, but researchers are investigating applications in breast, prostate, and brain tumors.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
Can a Six-Minute MRI Facilitate Detection of Multiple Sclerosis?
May 23rd 2025Recognition of the central vein sign with a six-minute MRI demonstrated comparable sensitivity for multiple sclerosis (MS) detection in comparison to oligoclonal band (OCB) assessment, which requires lumbar puncture, according to newly published research.